Chondrocyte extracellular matrix-derived peptide
AssigneeEyebio Korea
InventorJae Wook YANG
Life of this patent
Estimating the term…
Abstract
Disclosed is a novel peptide capable of preventing or treating ocular surface disease by inhibiting or improving pathological changes caused by neovascularization, opacification, fibrosis and inflammation of the cornea, the peptide having an amino acid sequence represented by SEQ ID NO: 1 and more particularly, provides a collagen type II α1-based peptide isolated from an animal chondrocyte cell-derived extracellular matrix and use thereof.
Claims6
A method of preventing or treating macular degeneration in a subject in need thereof, comprising:
- providing a pharmaceutical composition comprising a peptide having an amino acid sequence represented by SEQ ID NO:
- 1, as an active ingredient;
- and
- administering the pharmaceutical composition to the subject, wherein the macular degeneration is prevented or treated.
A health food for the preventing or improving macular degeneration comprising a peptide having an amino acid sequence represented by SEQ ID NO:
- 1, as an active ingredient.
Dependencies are inferred from the claim text.